SPRI | Cancer Screening In Inflammatory Bowel Disease: A Guide To Risk Management And Techniques (2019 EN)

Discussion in 'Medicine' started by Kanka, Jun 5, 2020.

  1. Kanka

    Kanka Well-Known Member Loyal User

    Messages:
    16,395
    Likes Received:
    485
    Trophy Points:
    83
    [​IMG]

    Author: Joseph D. Feuerstein (Editor), Adam S. Cheifetz (Editor)
    Full Title: Cancer Screening In Inflammatory Bowel Disease: A Guide To Risk Management And Techniques
    Publisher: Springer; 1st ed. 2019 edition (June 27, 2019)
    Year: 2019
    ISBN-13: 9783030153014 (978-3-030-15301-4), 9783030153007 (978-3-030-15300-7)
    ISBN-10: 3030153010, 3030153002
    Pages: 174
    Language: English
    Genre: Medicine: Internal Medicine
    File type: EPUB (True), PDF (True)
    Quality: 10/10
    Price: 77.99 €


    This book provides a concise, yet comprehensive overview of cancer risks in patients with inflammatory bowel disease (IBD), as well as the screening modalities used to reduce these risks. Each chapter presents a major malignancy that patients with IBD are at risk from, stemming from the disease itself or from the medications used to treat the disease. Malignancies covered include colorectal cancer, skin cancer, lymphoma, and other cancers. Cancer risk and screening with current and emerging drug therapies are also discussed.

    Written by experts in the field, Cancer Screening in Inflammatory Bowel Disease: A Guide to Risk Management and Techniques is a valuable resource for gastroenterologists, colorectal surgeons, and primary care physicians who treat and manage patients with inflammatory bowel disease.

    -------------